1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. United States >
  6. California >
  7. OREXIGEN Therapeutics >
  8. Ownership

OREXIGEN Therapeutics Ownership Overview

Life ScienceCompany

Who owns OREXIGEN Therapeutics?

OREXIGEN Therapeutics is owned by Nalpropion Pharmaceuticals. It was acquired in 2018.

OREXIGEN Therapeutics, Inc.

3344 N. Torrey Pines Court, Suite 200,
La Jolla, California 92037
United States,
(858) 875-8600
www.orexigen.com

Status Dates Investor(s)
Investment    Exit       
Current 2018-04-24 Nalpropion Pharmaceuticals, Inc.

Try Mergr Free — See This and 221,398+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal